PING Fan. Effect of transcatheter arterial chemoembolization combined with sorafenib in hepatocellular carcinoma patients in middle or advanced stage and nursing measures[J]. Journal of Clinical Medicine in Practice, 2020, 24(4): 122-124. DOI: 10.7619/jcmp.202004032
Citation: PING Fan. Effect of transcatheter arterial chemoembolization combined with sorafenib in hepatocellular carcinoma patients in middle or advanced stage and nursing measures[J]. Journal of Clinical Medicine in Practice, 2020, 24(4): 122-124. DOI: 10.7619/jcmp.202004032

Effect of transcatheter arterial chemoembolization combined with sorafenib in hepatocellular carcinoma patients in middle or advanced stage and nursing measures

More Information
  • Received Date: November 02, 2019
  • Objective To explore the effect and nursing measures of transcatheter arterial chemoembolization(TACE)combined with sorafenib in the treatment of hepatocellular carcinoma patients in middle or advanced stage. Methods The clinical data of 60 patients with advanced HCC treated by TACE and sorafenib were analyzed retrospectively. According to the random number table method, the patients were divided into control group and observation group, with 30 cases in each group. The control group received routine nursing, while the observation group received predictive nursing, and the incidence of toxic and side effects in the two groups was compared. The median survival time, disease progression time and mortality rate of the two groups were observed and recorded. Results There were no significant differences in median survival time, disease progression time and mortality rates between the two groups(P>0.05); the incidence of toxic and side effects(except for coagulation function disorders)in the observation group was lower than that in the control group, the difference was statistically significant(P<0.05). Conclusion TACE combined with sorafenib can significantly prolong the survival period of patients with advanced HCC, and the predictive nursing intervention can reduce the effect of toxic and side effects.
  • 王志美, 徐忠伟, 王佳宝, 等. 蟾酥活性成分协调索拉非尼通过下调Akt/NF-κB信号途径抑制肝癌HepG2细胞生长[J]. 中国药理学通报, 2017, 33(11): 1510-1516.
    魏续福, 蒲俊良, 郭振, 等. 肿瘤相关巨噬细胞促进索拉非尼耐药肝癌细胞的增殖及侵袭和迁移[J]. 细胞与分子免疫学杂志, 2017, 33(5): 617-622.
    郝明志, 林海澜, 陈起忠, 等. 重组人血管内皮抑制素联合肝动脉介入治疗对中晚期肝癌无疾病进展生存期的影响[J]. 临床肝胆病杂志, 2016, 32(1): 92-96.
    张艳丽, 冯保乐, 张目显, 等. 动脉灌注化疗栓塞术介入治疗联合放射性粒子对原发性肝癌患者CT灌注参数的影响[J]. 实用临床医药杂志, 2019, 23(17): 55-59.
    赵志敏. 术后早期促康护理措施对肝癌开放性手术患者胃肠功能恢复的效果[J]. 实用临床医药杂志, 2019, 23(14): 125-128

    , 132.
    万豪光, 许伟, 徐浩, 等. 经导管化疗栓塞联合经皮微波消融治疗中晚期肝癌64例的预后分析[J]. 介入放射学杂志, 2014, 23(6): 477-481.
    柴芳, 吴承容, 张小毅, 等. 恩替卡韦联合中药注射液对中晚期肝癌合并乙型肝炎病毒感染患者的疗效及预后的影响[J]. 中华医院感染学杂志, 2017, 27(13): 2916-2919.
    刘浩, 徐琴, 孙晓凤. 中晚期肝癌介入治疗患者的生存质量及预后影响因素分析[J]. 川北医学院学报, 2016, 31(5): 693-695.
    陈丹, 王凯冰, 李加桩, 等. 原发性肝癌的抗血管生成靶向治疗现状与挑战[J]. 中国肿瘤, 2017, 26(3): 203-209.
    王卫东, 黄巧胜, 倪嘉延, 等. TACE与索拉菲尼联合治疗中晚期肝癌临床研究的Meta分析[J]. 临床放射学杂志, 2015, 34(11): 1816-1821.
    朱楠, 鲁东, 肖景坤, 等. 肝动脉化疗栓塞联合射频消融术治疗中晚期肝癌的疗效[J]. 中国介入影像与治疗学, 2017, 14(4): 195-199.
    刘墨, 杨树法, 王海林, 等. 经导管肝动脉化疗栓塞(TACE)联合经皮射频消融术(RFA)治疗中晚期肝癌的疗效及预后影响因素分析[J]. 实用癌症杂志, 2015, 30(4): 616-619.
    王锋, 秦叔逵, 华海清, 等. 含奥沙利铂化疗方案治疗对索拉非尼耐药的晚期原发性肝癌的临床观察[J]. 临床肿瘤学杂志, 2014, 19(3): 226-230.
    丘奕文, 林丽珠, 黄学武, 等. 多中心回顾性队列研究中医药对中晚期原发性肝癌生存期的影响[J]. 广州中医药大学学报, 2014, 31(5): 699-705.
    李威, 满文玲, 郭欢庆, 等. TACE联合甲磺酸阿帕替尼治疗中晚期肝癌的临床研究[J]. 肿瘤药学, 2017, 7(1): 74-78.
    李慧, 路潜, 杨萍, 等. 原发性肝癌手术患者症状及延续照顾需求的研究[J]. 中华护理杂志, 2015, 50(6): 684-688.
    刘玉莲, 闻利红. 护理干预对肝癌介入术后患者并发症及生活质量的影响[J]. 安徽医药, 2014, 18(11): 2205-2206

    , 2207.
    孙亚利, 肖奇贵, 任洋, 等. 人文关怀护理对肝癌手术患者生活质量和负性情绪的影响研究[J]. 中国医学伦理学, 2016, 29(4): 704-706.
  • Related Articles

    [1]PENG Shunxian, TAO Hua, CHEN Xiaofeng, PENG Jifang, JIANG Shudi. Application value of C-reactive protein to albumin ratio combined with grip strength and serum prealbumin in patients with esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(17): 15-19, 26. DOI: 10.7619/jcmp.20242187
    [2]GAO Jianying, CAO Wenjuan, GAO Yuan. Values of D-dimer, prealbumin and soluble triggering receptor expressed on myeloid cells-1 in diagnosing severe pneumonia in children[J]. Journal of Clinical Medicine in Practice, 2023, 27(7): 108-112. DOI: 10.7619/jcmp.20223481
    [3]SHI Fang. Values of serum amyloid A and ratio of C reactive protein to prealbumin in diagnosis of acute exacerbation of chronic obstructive pulmonary disease complicated with lower respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 22-25. DOI: 10.7619/jcmp.202019007
    [4]LIU Xia. Effect of preventive nursing intervention on the incidence of hypostatic pneumonia in long term bedridden patients[J]. Journal of Clinical Medicine in Practice, 2016, (18): 32-34,38. DOI: 10.7619/jcmp.201618011
    [5]WANG Meilan. Significance of serum procalcitonin and prealbumin detections in the diagnosis of children with febrile diseases[J]. Journal of Clinical Medicine in Practice, 2015, (1): 89-91,104. DOI: 10.7619/jcmp.201501027
    [6]LI Yonghong. Value of serum CRP and PA levels in diagnosis and treatment of neonatal infections[J]. Journal of Clinical Medicine in Practice, 2014, (13): 63-65. DOI: 10.7619/jcmp.201413020
    [7]LENG Hongchun. Role of C reactive protein, prealbumin and white blood cell count and classification in differential diagnosis of children with infantile acute upper respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2014, (1): 49-52. DOI: 10.7619/jcmp.201401015
    [8]JU Jian-ping. Changes and clinical significance of serum prealbumin and C- reactive protein in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2012, (1): 97-98,101. DOI: 10.3969/j.issn.1672-2353.2012.01.033
    [9]PENG Qiao-lin. Relationship between the levels of serum prealbumin and the blood glucose control status in type 2 diabetic patients[J]. Journal of Clinical Medicine in Practice, 2011, (14): 41-42. DOI: 10.3969/j.issn.1672-2353.2011.14.017
    [10]WANG Da-ming, ZHU Bin, WANG Song-chuan. THE THERAPEUTIC EFFECTS OF CONTINUOUS RENAL REPLACEMENT THERAPY(CRRT) TO C-reactive PROTEIN(CRP) AND PREALBUMIN(PA) IN THE TREATMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME(MODS)[J]. Journal of Clinical Medicine in Practice, 2005, (8): 11-13. DOI: 10.3969/j.issn.1672-2353.2005.08.004

Catalog

    Article views (388) PDF downloads (8) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return